OncoVista Innovative Therapies Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.14 |
Market Cap |
$376.94 K |
Shares Outstanding |
23.56 M |
Public Float |
- |
Address |
14785 Omicron Drive San Antonio Texas 78245 United States |
Employees | - |
Website | - |
Updated | 07/08/2019 |
OncoVista Innovative Therapies, Inc. is a drug development company, which engages in the development and commercialization of targeted cancer therapies. The company produces drug discovery, registration strategies, and emerging technologies. Its products include Cordycepin and L-Nucleoside Conjugate. |